Related Experiment Video
Updated: Apr 20, 2026

Simultaneous Photothrombosis and Fiber Photometry to Induce and Monitor Ischemic Stroke in Behaving Mice
Published on: November 14, 2025
Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major
Teemu Vepsäläinen1, Markku Laakso, Seppo Lehto
1Department of Medicine, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, 20520 Turku, Finland. tkveps@utu.fi.
Insights
Prolonged P wave duration increases stroke mortality risk in type 2 diabetes patients with prevalent non-major macrovascular disease. This easily measurable factor may aid in stroke risk assessment for this population.
Area of Science:
- Cardiology
- Diabetology
- Epidemiology
Background:
- Prolonged P wave duration indicates delayed inter-atrial conduction, a potential predictor of cardiovascular disease (CVD).
- Type 2 diabetes is a known risk factor for atherosclerotic diseases, including stroke.
- The study investigates the prognostic value of P wave duration in Finnish type 2 diabetes patients with and without prevalent non-major macrovascular disease (PNMMVD).
Purpose of the Study:
- To evaluate the prognostic significance of prolonged P wave duration on total and stroke mortality.
- To assess the combined impact of P wave duration and PNMMVD on mortality risk in type 2 diabetes patients.
- To determine if P wave duration is an independent predictor of stroke mortality in this cohort.
Main Methods:
- An 18-year follow-up study of 739 middle-aged Finnish type 2 diabetes patients without prior major CVD events.
- Patients were stratified by P wave duration (<114 ms vs. ≥114 ms) and presence of PNMMVD (coronary heart disease or claudication).
- Cox proportional hazards models were employed to analyze the association between P wave duration, PNMMVD, and mortality risk.
Main Results:
- A total of 509 deaths occurred, with 59 attributed to stroke during the follow-up period.
- Prolonged P wave duration was associated with a 2.45-fold increased risk of stroke mortality specifically among patients with PNMMVD.
- No significant relationship between P wave duration and stroke mortality was observed in patients without PNMMVD.
Conclusions:
- P wave duration is a significant predictor of stroke mortality in type 2 diabetes patients with prevalent non-major macrovascular disease.
- This easily measurable electrocardiographic parameter warrants further investigation for its role in stroke risk stratification.
- Larger studies are needed to confirm the importance of P wave duration in estimating stroke risk within this specific patient group.
Background:
Prolonged P wave duration is a marker of delayed inter-atrial conduction which may predict cardiovascular disease (CVD). Type 2 diabetes is a risk factor for all atherosclerotic manifestations including stroke. We evaluated the prognostic significance of prolonged P wave duration among middle-aged Finnish type 2 diabetes patients with and without prevalent non-major macrovascular disease (PNMMVD) with respect to total and stroke mortality.
Methods:
We followed up for 18 years 739 type 2 diabetic patients without previous major CVD event at baseline. Participants were stratified according to P wave duration (<114 or ≥ 114 ms) and PNMMVD (i.e. coronary heart disease defined as ischaemic ECG changes and typical symptoms of angina pectoris, or claudication; yes or no). The Cox proportional hazards model was used to estimate the joint association between P wave duration, PNMMVD and the mortality risk.
Results:
During the follow-up, 509 patients died, and 59 of them died from stroke. Those who had prolonged P wave duration had 2.45 (95% confidence interval: 1.11-5.37) increased stroke mortality among PNMMVD patients. In patients without PNMMVD, there was no relationship between P wave duration and stroke mortality.
Conclusions:
As an easily measurable factor P wave duration merits further studies with higher number of patients to evaluate its importance in the estimation of stroke risk in type 2 diabetic patients with PNMMVD.
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Nephropathy
Ischemic Stroke ll: Pathophysiology
Type I Diabetes II: Pathophysiology

